Arctostaphylos uva-ursi leaf

Last content change Dec 27, 2015checked dailysee data sync status

This product has been discontinued

DISCLAIMER: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

Active ingredient: Arctostaphylos Uva-Ursi Leaf 1 [hp_X]
Other brand names: Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
View full label-group details →
Dosage form: Tablet
Route: Oral
Prescription status: Homeopathic
Marketed in the U.S.: Since 2015
Label revision date: December 27, 2015
Manufacturer Document: Prescribing information, PDF file

Active ingredient: Arctostaphylos Uva-Ursi Leaf 1 [hp_X]
Other brand names: Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Boiron)
Uva Ursi (by Rxhomeo Private Limited D. B. a. Rxhomeo, Inc)
View full label-group details →
Dosage form: Tablet
Route: Oral
Prescription status: Homeopathic
CSA schedule: Not a scheduled drug
Marketed in the U.S.: Since 2015
Label revision date: December 27, 2015
Manufacturer: Rxhomeo Private Limited d. b. a. Rxhomeo, Inc
NDC root: 15631-0702
Manufacturer Document: Prescribing information, PDF file

Packaging Info (8 NDCs)

Packaging & NDC Codes (8)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

I'm sorry, but it seems that the bullet list you provided does not contain specific information about the drug's name, description, or its uses. Without these details, I cannot create a summary about what the drug is or what it is used for. If you have more information or a different list, please share it, and I'll be happy to help!

Uses

You may be prescribed this medication for a specific condition as determined by your physician. It's important to follow their guidance on how to use it effectively.

There are no known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects associated with this medication. Always consult your healthcare provider if you have any questions or concerns about its use.

Dosage and Administration

When taking this medication, adults should take either 4 or 6 tablets by mouth three times a day, or follow your doctor’s specific recommendations. If you are giving this medication to a child who is 2 years or older, they should take half of the adult dose.

Make sure to take the tablets by mouth at the same times each day to maintain a consistent level of the medication in your system. If you have any questions about the dosage or how to administer it, don’t hesitate to reach out to your healthcare provider for guidance.

Warnings and Precautions

This product is intended for short-term use to help with self-limiting conditions, meaning it should only be used for issues that typically resolve on their own. If your symptoms do not improve within four days or if they worsen, it’s important to stop using the product and consult a healthcare professional for further guidance.

If you are pregnant or nursing, please seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children to prevent accidental ingestion. Additionally, do not use the product if the cap seal is broken or missing, and remember to close the cap tightly after each use to maintain its effectiveness.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs or feel unwell after taking the medication, seek medical help right away.

In case of an overdose, contact your healthcare provider or local emergency services immediately. They can provide the necessary assistance and guidance. Always remember that it's better to be safe and get checked if you have any concerns about your health.

Storage and Handling

To ensure the best performance and safety of your product, store it in a cool, dark place. This helps maintain its effectiveness and prevents any degradation that could occur from exposure to heat or light.

When handling the product, always ensure that you do so in a clean environment to avoid contamination. Following these simple storage and handling guidelines will help you use the product safely and effectively.

Additional Information

This medication is taken orally and is intended for self-limiting conditions, meaning it should help with symptoms that typically resolve on their own. If your symptoms do not improve within four days or if they worsen, you should stop using the product and consult a healthcare professional.

If you are pregnant or nursing, it's important to seek advice from a healthcare provider before using this medication. Always keep this and all medications out of reach of children, and do not use the product if the cap seal is broken or missing. Remember to close the cap tightly after each use to ensure safety.

FAQ

What is the recommended dosage for adults?

Adults should take 4 or 6 tablets by mouth, three times daily or as suggested by a physician.

What is the dosage for children?

Children aged 2 years and older should take half the adult dose.

How should this medication be taken?

This medication should be taken by mouth, three times daily.

What should I do if my symptoms do not improve?

If your symptoms do not improve in 4 days or worsen, discontinue use and seek assistance from a health professional.

Is it safe to use this product during pregnancy or while nursing?

As with any drug, you should seek professional advice before taking this product if you are pregnant or nursing.

How should I store this medication?

Store this medication in a cool, dark place.

What precautions should I take with this medication?

Keep this and all medications out of reach of children, do not use if the cap seal is broken or missing, and close the cap tightly after use.

Packaging Info

This section summarizes the homeopathic presentations of Uva Ursi. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Uva Ursi.

	1 in blister pack 1 item total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	4 in blister pack 4 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	50 in container 50 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	100 in container 100 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	250 in container 250 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	500 in container 500 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	1000 in container 1000 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	10000 in container 10000 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose

Manufacturer Insert (PDF)

This file includes usage instructions and other product details provided by the manufacturer. This is not an FDA-approved drug.

View manufacturer document (PDF)

Description

Description:

This product contains UVA URSI HPUS 1X and higher as the active ingredient. The formulation includes lactose as an inactive ingredient. The product is characterized by a white color, round shape, and a size of 3 mm. The ingredient name is Arctostaphylos uva-ursi leaf (UNII: 3M5V3D1X36), with a strength of 1 hp_X. The inactive ingredient, lactose, is identified by the UNII: J2B2A4N98G.

Packaging & NDC

This section summarizes the homeopathic presentations of Uva Ursi. Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Uva Ursi.

	1 in blister pack 1 item total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	4 in blister pack 4 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	50 in container 50 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	100 in container 100 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	250 in container 250 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	500 in container 500 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	1000 in container 1000 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose
	10000 in container 10000 items total	Tablet	1 [hp_X]
Product details Regulatory status — Discontinued NSDE (NDC Directory) reports this NDC as Not Marketed. FDA record dates for this NDC: NSDE file: February 16, 2026 → status: Not marketed Type Type 0: Not a Combination Product Active ingredients Arctostaphylos Uva-Ursi Leaf 1 [hp_X] Inactive ingredients lactose

Manufacturer Insert (PDF)

This is the product document submitted by Rxhomeo Private Limited d. b. a. Rxhomeo, Inc for Uva Ursi. It includes information on ingredients, suggested use, and labeling language. This product is not FDA-approved.

View product insert (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the manufacturer-supplied FDA Structured Product Label (DailyMed) for Uva Ursi, retrieved February 17, 2026 by a validated AI data-extraction workflow.

All dosage forms and strengths provided by the manufacturer are listed in the Packaging & NDC Codes section above.

Homeopathic drug products are not reviewed by FDA for safety or effectiveness; information is reproduced without modification.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update: February 17, 2026

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.